MAPT and Alzheimer disease: While some studies suggest that changes in the content of p-tau in CSF occur later in the disease process than those of Aβ, there is strong evidence showing that the CSF levels of Aβ, but not those of t-tau, are altered already five to ten years before the appearance of the clinical signs of Alzheimer’s dementia.